GMP Page

Download the full article (PDF) Introduction The emergence of chimeric antigen receptor (CAR)-based immunotherapies has revolutionized the treatment of hematologic malignancies. While CAR-T cell therapies dominate the clinical landscape, enthusiasm is growing for CAR-engineered natural killer (CAR-NK) cells, which leverage the cytotoxic capacity of NK cells with the specificity of CAR constructs. Natural killer (NK) […]

Making CAR NK Cell Therapy Accessible for Everybody

Recent Articles​

Inhaler-Based Immunotherapy for Lung Cancer
Anti-Viral Therapy

Inhaler-Based Immunotherapy for Lung Cancer

Lung cancer is among the most lethal malignancies worldwide, with limited therapeutic success despite advancements in immunotherapy. Immune checkpoint inhibitors (ICIs), particularly those targeting PD-1/PD-L1 pathways, have marked a paradigm

Read More »

Recent Articles